Onconova Therapeutics, Inc. Warrants
ONTXW
ONTXW was delisted on the 23rd of July, 2021.
2 hedge funds and large institutions have $15K invested in Onconova Therapeutics, Inc. Warrants in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
0% more capital invested
Capital invested by funds: $15K → $15K ($0)
50% less funds holding
Funds holding: 4 → 2 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$3.85K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.43K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3K |
| 3 |
VF
Virtu Financial
New York
|
-$3K |
ONTXW Hedge Fund Activity: Q1 2021 in Review
2 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Onconova Therapeutics, Inc. Warrants (ONTXW) for Q1 2021, worth a combined $15K — unchanged from a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ONTXW and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $3.85K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $6K sold.
- 2 institutional investors held Onconova Therapeutics, Inc. Warrants (ONTXW) as of Q1 2021, down from 4 in Q4 2020.
- Funds reported $15K of Onconova Therapeutics, Inc. Warrants stock for Q1 2021, unchanged quarter-over-quarter.
- 1 fund opened new Onconova Therapeutics, Inc. Warrants positions in Q1 2021 and 3 closed out, a net change of -2 holders.
- The largest Onconova Therapeutics, Inc. Warrants buyer in Q1 2021 was Two Sigma Securities, an estimated $3.85K added.
- The largest Onconova Therapeutics, Inc. Warrants seller in Q1 2021 was Susquehanna International Group, an estimated $6K sold.
Based on aggregated 13F filings for Q1 2021.